118 related articles for article (PubMed ID: 10376320)
1. Preparation of [186Re]Re-DMSA and its bio-distribution studies.
Kothari K; Pillai MR; Unni PR; Shimpi HH; Noronha OP; Samuel AM
Appl Radiat Isot; 1999 Jul; 51(1):43-9. PubMed ID: 10376320
[TBL] [Abstract][Full Text] [Related]
2. Carrier effect on radiolabeling the polynuclear pentavalent rhenium-186 complex of dimercaptosuccinic acid at alkaline pH: 186Re(V)-DMS.
Horiuchi K; Saji H; Yokoyama A
Nucl Med Biol; 1999 Oct; 26(7):771-9. PubMed ID: 10628556
[TBL] [Abstract][Full Text] [Related]
3. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
4. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
5. Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complex.
Singh J; Reghebi K; Lazarus CR; Clarke SE; Callahan AP; Knapp FF; Blower PJ
Nucl Med Commun; 1993 Mar; 14(3):197-203. PubMed ID: 8384352
[TBL] [Abstract][Full Text] [Related]
6. Preparation, stability studies and pharmacological behavior of [186Re]Re-HEDP.
Kothari K; Pillai MR; Unni PR; Shimpi HH; Noronha OP; Samuel AM
Appl Radiat Isot; 1999 Jul; 51(1):51-8. PubMed ID: 10376321
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of [186Re]rhenium(V)dimercaptosuccinic acid: a possible tumour radiotherapy agent.
Bisunadan MM; Blower PJ; Clarke SE; Singh J; Went MJ
Int J Rad Appl Instrum A; 1991; 42(2):167-71. PubMed ID: 1648035
[TBL] [Abstract][Full Text] [Related]
8. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake.
Dadachova E; Chapman J
Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor.
Park JY; Lee TS; Choi TH; Cheon GJ; Choi CW; Awh OD
Nucl Med Biol; 2007 Nov; 34(8):1029-36. PubMed ID: 17998108
[TBL] [Abstract][Full Text] [Related]
10. An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)](-): efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid.
Bolzati C; Boschi A; Uccelli L; Duatti A; Franceschini R; Piffanelli A
Nucl Med Biol; 2000 Apr; 27(3):309-14. PubMed ID: 10832088
[TBL] [Abstract][Full Text] [Related]
11. Uptake of the 188Re(V)-DMSA complex by cervical carcinoma cells in nude mice: pharmacokinetics and dosimetry.
García-Salinas L; Ferro-Flores G; Arteaga-Murphy C; Pedraza-López M; Hernández-Gutiérrez S; Azorin-Nieto J
Appl Radiat Isot; 2001 Mar; 54(3):413-8. PubMed ID: 11214875
[TBL] [Abstract][Full Text] [Related]
12. Reliable preparation of 99mTc (V) DMSA by a simple modified method using a commercial kit for 99mTc (III) DMSA.
Washburn LC; Biniakiewicz DS; Maxon HR
Nucl Med Biol; 1995 Jul; 22(5):689-91. PubMed ID: 7581181
[TBL] [Abstract][Full Text] [Related]
13. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation.
Oh SJ; Won KS; Moon DH; Cheon JH; Ha HJ; Jeong JM; Lee HK
Nucl Med Commun; 2002 Jan; 23(1):75-81. PubMed ID: 11748441
[TBL] [Abstract][Full Text] [Related]
14. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
15. Preparation and biological characterization of isomeric 188Re(V) oxocomplexes with tetradentate S4 ligands derived from meso-dimercaptosuccinic acid for labeling of biomolecules.
Seifert S; Heinrich T; Jentschel C; Smuda C; Bergmann R; Pietzsch HJ
Bioconjug Chem; 2006; 17(6):1601-6. PubMed ID: 17105241
[TBL] [Abstract][Full Text] [Related]
16. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
17. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
[TBL] [Abstract][Full Text] [Related]
19. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
20. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M
Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]